45.4p6.4 years ; HbsAgj l 1, anti-HCVj l 24, both HbsAgj and anti-HCVj l 2) ; group C (grading score ranging from 13 to 18) consisted of 14 patients (7 male, 7 female, mean age 53.8p8.6 years ; HbsAgj l 4, antiHCVj l 10, five patients showed initial histological features of cirrhosis). The 74 patients with liver cirrhosis (44 male, 30 female, mean age 52.8p7.2 years ; HbsAgj l 12, anti-HCVj l 62) were divided according to the Child-Pugh classification into three classes : A (n l 19), B (n l 36) and C (n l 19). A group of healthy volunteers (12 male, 9 female, mean age 50.0p4.0 years) served as controls.
Compared with controls, serum VEGF concentrations were lower in patients with chronic hepatitis. The lowest level of serum VEGF was found in the patients in group C, whereas the highest level of serum VEGF was found in the patients in group A ( Figure 1A ). In group A and group B the serum VEGF levels and grading scores were inversely correlated (r lk0.318, P l 0.005 and r lk0.436, P l 0.023 respectively) ; in group C this correlation was not statistically significant (r lk0.507, P l 0.064). The mean staging score for fibrosis was lower in group A (0.63p0.59) than in group B (1.52p0.58, P 0.0001 versus group A) and group C (3.57p1.28, P 0.0001 versus group A and group B), and inversely correlated with serum VEGF levels in group A (r lk0.340, P l 0.042) and group C (r lk0.597, P l 0.024).
In cirrhotic patients, serum VEGF levels decreased according to progression of the disease, according to the Child-Pugh classification ( Figure 1B) . The VEGF levels in pooled serum from cirrhotic patients were lower than the levels in the pooled serum from patients with hepatitis (P 0.05).
In spite of the points raised above, serum VEGF concentrations were unrelated to aetiology, age, gender, serum AST, ALT, total and fractionated bilirubin, cholesterol, triacylglycerol, alkaline phosphatase, γ-glutamyltransferase, total protein levels, plasma fibrinogen concentrations, coagulation indexes and, where monitored (in 7 patients), fibrinogen degradation product levels. Only
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in the pooled serum of cirrhotic patients was a direct significant correlation between albumin and VEGF concentrations found (r l 0.398, P 0.001).
In conclusion, the present study expands upon previous data [4] showing that serum VEGF levels decrease in cirrhotic patients according to the Child-Pugh classification and, in patients with chronic hepatitis, with the severity of histological findings. However, in agreement with previous findings [4] , VEGF levels did not correlate with blood biochemical indexes of hepatocyte injury and\or function. Therefore hepatic VEGF release and\or production is abnormal in chronic liver diseases and decreases with advancing liver dysfunction. Mechanisms regulating VEGF release from damaged hepatocytes and the role of sinusoidal endothelial cells in VEGF production during chronic liver diseases require further investigation. Our data suggest that measurement of serum VEGF concentrations may be useful, in conjunction with other markers of liver function, in the prognosis of chronic liver disease.
